Association between marked fetal heart rate variability and neonatal acidosis: A prospective cohort study.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
03 2023
Historique:
revised: 08 10 2022
received: 03 07 2022
accepted: 17 10 2022
pubmed: 19 11 2022
medline: 8 2 2023
entrez: 18 11 2022
Statut: ppublish

Résumé

To assess the association between marked variability in fetal heart rate (FHR) and neonatal acidosis. Bicentric prospective cohort study. From January 2019 to December 2019, in two French tertiary care maternity units. Women in labour at ≥37 weeks of gestation, with continuous FHR monitoring until delivery and with the availability of umbilical arterial pH. Women with intrauterine fetal death or medical termination, multiple pregnancies, non-cephalic presentation or planned caesarean delivery were excluded. The exposure was marked variability in FHR in the 60 minutes before delivery, defined as a variability greater than 25 beats per minute, with a minimum duration of 1 minute. To assess the association between marked variability and neonatal acidosis, we used multivariable modified Poisson regression modelling. We then conducted subgroup analyses according to the US National Institute of Child Health and Human Development (NICHD) category of the associated fetal heart rate. Neonatal acidosis, defined as an umbilical artery pH of ≤7.10. Among the 4394 women included, 177 (4%) had marked variability in fetal heart rate in the 60 minutes before delivery. Acidosis occurred in 6.0% (265/4394) of the neonates. In the multivariable analysis, marked variability was significantly associated with neonatal acidosis (aRR 2.30, 95% CI 1.53-3.44). In subgroup analyses, the association between marked variability and neonatal acidosis remained significant in NICHD category-I and category-II groups. Marked variability was associated with a twofold increased risk of neonatal acidosis.

Identifiants

pubmed: 36398385
doi: 10.1111/1471-0528.17345
pmc: PMC10108100
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

407-414

Informations de copyright

© 2022 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.

Références

J Matern Fetal Neonatal Med. 2006 May;19(5):289-94
pubmed: 16753769
Int J Gynaecol Obstet. 2015 Oct;131(1):13-24
pubmed: 26433401
Am J Obstet Gynecol. 2017 Feb;216(2):163.e1-163.e6
pubmed: 27751795
BJOG. 2022 Nov;129(12):2070-2081
pubmed: 35596699
BJOG. 2023 Mar;130(4):407-414
pubmed: 36398385
Am J Obstet Gynecol. 2018 May;218(5):523.e1-523.e12
pubmed: 29408586
Am J Obstet Gynecol. 2011 Jun;204(6):455-6
pubmed: 21752747
BJOG. 2010 Mar;117(4):429-37
pubmed: 20025619
Obstet Gynecol. 2011 Oct;118(4):803-8
pubmed: 21897312
Obstet Gynecol. 2010 Nov;116(5):1232-40
pubmed: 20966730
Am J Obstet Gynecol. 2011 Oct;205(4):378.e1-5
pubmed: 21864826
Am J Obstet Gynecol. 2017 Aug;217(2):167-175
pubmed: 28427805
BJOG. 2012 Jun;119(7):824-31
pubmed: 22571747
Obstet Gynecol. 2020 Feb;135(2):469-471
pubmed: 31923077
Am J Obstet Gynecol. 2013 Aug;209(2):89-97
pubmed: 23628263
Obstet Gynecol. 2009 Jul;114(1):192-202
pubmed: 19546798
BJOG. 2005 Apr;112(4):418-23
pubmed: 15777438
Reprod Sci. 2009 May;16(5):509-17
pubmed: 19164481
J Matern Fetal Neonatal Med. 2019 Jan;32(1):117-124
pubmed: 28851252
J Perinatol. 2020 Jan;40(1):56-62
pubmed: 31578422
Obstet Gynecol. 2008 Sep;112(3):661-6
pubmed: 18757666
Am J Obstet Gynecol. 2011 Jun;204(6):491.e1-10
pubmed: 21752753
Am J Obstet Gynecol. 2003 Mar;188(3):820-3
pubmed: 12634664
Obstet Gynecol. 2003 Aug;102(2):333-7
pubmed: 12907109
JAMA Netw Open. 2020 Feb 5;3(2):e1921363
pubmed: 32074288
Am J Obstet Gynecol. 2015 Nov;213(5):681.e1-6
pubmed: 26193688
Acta Obstet Gynecol Scand. 2008;87(3):300-6
pubmed: 18307069
Am J Obstet Gynecol. 1976 Jun 1;125(3):290-305
pubmed: 1275022
Am J Obstet Gynecol. 1999 Nov;181(5 Pt 1):1122-7
pubmed: 10561630

Auteurs

Lola Loussert (L)

Department of Obstetrics and Gynecology, CHU Toulouse, Toulouse, France.

Paul Berveiller (P)

Department of Obstetrics and Gynecology, CHI Poissy, Paris, France.

Alexia Magadoux (A)

Department of Obstetrics and Gynecology, CHI Poissy, Paris, France.

Michael Allouche (M)

Department of Obstetrics and Gynecology, CHU Toulouse, Toulouse, France.

Christophe Vayssiere (C)

Department of Obstetrics and Gynecology, CHU Toulouse, Toulouse, France.
CERPOP, UMR 1295, Team SPHERE (Study of Perinatal, Pediatric and Adolescent Health: Epidemiological Research and Evaluation) Toulouse III University, Toulouse, France.

Charles Garabedian (C)

Department of Obstetrics and Gynecology, CHU Lille, Lille, France.

Paul Guerby (P)

Department of Obstetrics and Gynecology, CHU Toulouse, Toulouse, France.
Toulouse Institute for Infectious and Inflammatory Diseases, Inserm UMR 1291 - CNRS UMR 5051, University Toulouse III, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH